Home
  • Our Company
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Culture, Diversity and Inclusion
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Decentralized Solutions
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Medical Affairs
    • Commercialization
      • Advertising
      • AnswerSuite
      • Behavioral Insights
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Full-Service Commercial
      • Medical Communications
      • Policy and Advocacy
      • Public Relations
      • Reputation and Risk Management
      • Selling Solutions
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease and Vaccines
      • Ophthalmology
      • Respiratory
      • Women's Health
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Patient Voice
      • Pediatrics
      • Rare Diseases
  • Insights Hub
  • Careers
  • インサイト ハブ
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • News Releases
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Standard Contractual Clauses for Suppliers
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Healthcare Equity
Trends
  • Diversity, Equity, and Inclusion

Healthcare Equity

February 11, 2021
Content 

 

Subscribe to our Newsletter

 

What can individual brands and companies do to ensure equal access to scientific discovery and long-trusted therapies?

Healthcare Equity

2021 Health Trends

Columns 
Content 
Image or Video 

Trends_2021_03.png

Healthcare Equity - 2021 Health Trends
Content 

In healthcare so much can seem unequal—from access to care to participation in clinical trials, but we’ve reached a critical inflection point for change. Today, we are seeing our industry act on behalf of equality. Leading life science organizations have teams dedicated to inclusion and diversity.

 

Clinical organizations are actively working to build both trust and awareness while making trials more portable and flexible to enable people to participate from anywhere. 

 

For the first time, our industry is truthfully acknowledging our own harsh realities, signaling an opportunity to do better. Clinical trials are part of a continuum, and when our healthcare system fails minority populations by every metric, trial representation reflects the dereliction. We must embrace an ideal that is simple in essence: Study new medications in patients who represent the burden of disease. It is not about box-checking quotas. We must be intentional in our trial designs—listening, acknowledging, and maintaining momentum even after the pandemic subsides.  

 

One promising sign: our commercial organizations are now focusing on how social determinants affect outcomes and creating programs that build the right environments for success.

 

Download the full Healthcare Equity trend report to learn what companies can do to increase diversity in clinical research, ensure equal access to scientific discovery, and together forge an inclusive healthcare ecosystem.
 

Did you know...

Columns 
Content 
Image or Video 

Average 76 percent caucasian study participants .png

Average 76 percent caucasian study participants

78%: The vast majority of clinical trial participants in the United States are Caucasian, despite the fact minorities make up 40% of the population. On average, 78% of participants in trials for new drugs were White and only 16% were Black or African American.

— FDA, 2020

Content 
Image or Video 

Only 25 years since NIH required diversity in clinical trials.png

Only 25 years since NIH required diversity in clinical trials

25 Years: It’s been a quarter of a century since the NIH mandated the inclusion of women and minority groups in all NIH-funded clinical research in a manner that is appropriate to the scientific question under study.

— NIH, 2020

 

More Insights Hub content on Diversity, Equity & Inclusion

The 2021 Health Trends Series
Transformative Partnerships
Syneos Health Insights Hub Live: Acting on Equity
Download
Previous Next

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chapters

Chapter:
7
Omnichannel Maturity
Chapter:
8
The Physician Context
Chapter:
9
Peer-to-Peer Realignment
Chapter:
10
Transformative Partnerships
Chapter:
11
Healthcare Equity
Chapter:
12
Virtual Engagement

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »
Branded Logo
Contact Us Today Share

Related Content

The 2021 Health Trends Series
July 1, 2021
Transformative Partnerships
February 4, 2021
Syneos Health Insights Hub Live: Acting on Equity
July 2, 2020
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture. Contact Us

Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • 労働者派遣法に基づく情報公開
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2023 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Online Tracking Opt-Out